ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

U.S. specialty healthcare benefits manager eviCore is exploring a sale of the company or an initial public offering, hoping for a valuation of more than $4 billion, including debt, people familiar ...

T. Christian Miller, a reporter at ProPublica, explains how EviCore’s tool is manipulated to increase denials and cut costs. Some of the biggest health insurers in the country are turning to an ...

In what the company says will create a "comprehensive patient benefit management solution," prescription benefit services company Express Scripts is acquiring eviCore Healthcare for $3.6 billion.

While prior authorization is a key tool in an insurer's arsenal as it thinks about managing costs, the process remains a key source of friction with physicians. Amid a nationwide conversation around ...

FRISCO, Texas--(BUSINESS WIRE)--Soleo Health, an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today it was selected as a preferred provider by ...

Express Scripts said it will buy privately held medical benefits management firm, eviCore for $3.6 billion as the nation’s health payment shifts from fee-for-service medicine to value-based care. The ...

Express Scripts has reached a deal to acquire medical benefits management outfit eviCore healthcare in a deal that gives the pharmacy benefits manager additional heft as health giants jockey for power ...

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

(Reuters) - U.S. specialty healthcare benefits manager eviCore is exploring a sale of the company or an initial public offering, hoping for a valuation of more than $4 billion, including debt, people ...